Irritable bowel syndrome (IBS) is a common digestive disorder with unclear causes, affecting about 10% of the global population. Researchers have now discovered that opioid delta-receptor agonists may ...
University of Mississippi researchers have discovered how a compound found in cannabis might be used to mitigate the negative ...
Using an innovative and recently validated animal model of IBS, the researchers showed that opioid delta-receptor agonists can ameliorate stress-induced IBS symptoms by acting on the insular cortex of ...
New research suggests that Ozempic and similar weight loss medications have the potential to be as big a game changer in ...
Federal officials approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid​ medications like Vicodin and OxyContin.
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals.
The FDA granted approval for Journavx after clinical trials demonstrated its effectiveness in post-surgical pain relief ...
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
A new type of non-opioid painkiller, aimed at treating short-term pain in adults, has been approved by the US Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback